dnaJ Peptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dnaJ Peptide, covering 2007-07-31 to 2007-07-31. Get the full timeline:
Most recent: Clinical Trial Update: dnaJ Peptide for Relieving Rheumatoid Arthritis [Phase 2]